191 related articles for article (PubMed ID: 11888656)
1. Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors.
Cihlar T; Birkus G; Greenwalt DE; Hitchcock MJ
Antiviral Res; 2002 Apr; 54(1):37-45. PubMed ID: 11888656
[TBL] [Abstract][Full Text] [Related]
2. Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors.
Birkus G; Hitchcock MJ; Cihlar T
Antimicrob Agents Chemother; 2002 Mar; 46(3):716-23. PubMed ID: 11850253
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors.
Venhoff N; Setzer B; Melkaoui K; Walker UA
Antivir Ther; 2007; 12(7):1075-85. PubMed ID: 18018766
[TBL] [Abstract][Full Text] [Related]
4. ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase.
Naeger LK; Margot NA; Miller MD
Antimicrob Agents Chemother; 2002 Jul; 46(7):2179-84. PubMed ID: 12069972
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors.
Hill SA; Lloyd PA; McDonald S; Wykoff J; Derse D
J Infect Dis; 2003 Aug; 188(3):424-7. PubMed ID: 12870124
[TBL] [Abstract][Full Text] [Related]
6. Differential susceptibility of retroviruses to nucleoside analogues.
Rosenblum LL; Patton G; Grigg AR; Frater AJ; Cain D; Erlwein O; Hill CL; Clarke JR; McClure MO
Antivir Chem Chemother; 2001 Mar; 12(2):91-7. PubMed ID: 11527046
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset).
Geleziunas R; Gallagher K; Zhang H; Bacheler L; Garber S; Wu JT; Shi G; Otto MJ; Schinazi RF; Erickson-Viitanen S
Antivir Chem Chemother; 2003 Jan; 14(1):49-59. PubMed ID: 12790516
[TBL] [Abstract][Full Text] [Related]
8. In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs.
Hukezalie KR; Thumati NR; Côté HC; Wong JM
PLoS One; 2012; 7(11):e47505. PubMed ID: 23166583
[TBL] [Abstract][Full Text] [Related]
9. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro.
Caron M; Auclair M; Lagathu C; Lombès A; Walker UA; Kornprobst M; Capeau J
AIDS; 2004 Nov; 18(16):2127-36. PubMed ID: 15577645
[TBL] [Abstract][Full Text] [Related]
10. Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir.
Hossain MM; Coull JJ; Drusano GL; Margolis DM
Antiviral Res; 2002 Jul; 55(1):41-52. PubMed ID: 12076750
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea enhances the activities of didanosine, 9-[2-(phosphonylmethoxy)ethyl]adenine, and 9-[2-(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolates.
Palmer S; Shafer RW; Merigan TC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2046-50. PubMed ID: 10428934
[TBL] [Abstract][Full Text] [Related]
12. BMS-986001, an HIV nucleoside reverse transcriptase inhibitor, does not degrade mitochondrial DNA in long-term primary cultures of cells isolated from human kidney, muscle, and adipose tissue.
Wang F; Flint OP
Antimicrob Agents Chemother; 2013 Dec; 57(12):6205-12. PubMed ID: 24080659
[TBL] [Abstract][Full Text] [Related]
13. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D attenuates nucleoside reverse transcriptase inhibitor induced human skeletal muscle mitochondria DNA depletion.
Campbell GR; Pallack ZT; Spector SA
AIDS; 2013 Jun; 27(9):1397-401. PubMed ID: 23435299
[TBL] [Abstract][Full Text] [Related]
15. Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells.
Carter MM; Torres SM; Cook DL; McCash CL; Yu M; Walker VE; Walker DM
Environ Mol Mutagen; 2007; 48(3-4):239-47. PubMed ID: 17358029
[TBL] [Abstract][Full Text] [Related]
16. The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
Miller V; Stürmer M; Staszewski S; Gröschel B; Hertogs K; de Béthune MP; Pauwels R; Harrigan PR; Bloor S; Kemp SD; Larder BA
AIDS; 1998 May; 12(7):705-12. PubMed ID: 9619801
[TBL] [Abstract][Full Text] [Related]
17. Tenofovir, adefovir, and zidovudine susceptibilities of primary human immunodeficiency virus type 1 isolates with non-B subtypes or nucleoside resistance.
Palmer S; Margot N; Gilbert H; Shaw N; Buckheit R; Miller M
AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1167-73. PubMed ID: 11522186
[TBL] [Abstract][Full Text] [Related]
18. In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells.
Vidal F; Domingo JC; Guallar J; Saumoy M; Cordobilla B; Sánchez de la Rosa R; Giralt M; Alvarez ML; López-Dupla M; Torres F; Villarroya F; Cihlar T; Domingo P
Antimicrob Agents Chemother; 2006 Nov; 50(11):3824-32. PubMed ID: 16940060
[TBL] [Abstract][Full Text] [Related]
19. Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection.
Fung HB; Stone EA; Piacenti FJ
Clin Ther; 2002 Oct; 24(10):1515-48. PubMed ID: 12462284
[TBL] [Abstract][Full Text] [Related]
20. In vitro combination studies of tenofovir and other nucleoside analogues with ribavirin against HIV-1.
Margot NA; Miller MD
Antivir Ther; 2005; 10(2):343-8. PubMed ID: 15865229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]